Skip to content

Effectiveness of technology's use for the management and control of type 2 Diabetes Mellitus. Study in a population residing in Complexo do Alemão, Rio de Janeiro

Effectiveness of an Educational System and Remote Data Collection of patient information by Mobile Devices and the Internet in the metabolic control of type 2 Diabetes Mellitus A controlled study in a population residing in Complexo do Alemão, Rio de Janeiro

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-98v2y84
Enrollment
Unknown
Registered
2023-01-10
Start date
2017-04-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

An open-label, parallel-group randomized trial was conducted for a mobile app intervention vs. usual care in a community in vulnerable socioeconomic conditions. Electronic medical records were used to

Sponsors

Hospital Universitário Pedro Ernesto
Lead Sponsor
Universidade do Estado do Rio de Janeiro
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: The study selected participants with a previous diagnosis of type 2 diabetes according to the American Diabetes Association criteria. Adults aged between 18 and 75 years; with a previous diagnosis of type 2 diabetes or fasting blood glucose >126 mg/dL and/or random blood glucose >200 mg/dL; under non-pharmacological treatment; oral antihyperglycemic agents or insulin use were included. All the participants received free internet access during the study. Thus, it was considered inclusion criteria to live in areas with available cabling for the establishment of an internet connection, which was provided by the study group

Exclusion criteria

Exclusion criteria: Patients with type 1 diabetes; other types of diabetes; and pregnant women were excluded

Design outcomes

Primary

MeasureTime frame
Expected Outcome 1. It is expected to find an improvement in glycemic control, assessed through Glycated Hemoglobin before and after the intervention. A variation (reduction) of at least 0.5 percent is expected between pre- and post-intervention measurements;Outcome found 1. We observed that the intervention group had a greater reduction in glycated hemoglobin compared to the control group in the evaluated period (median variation of -0.2 (-0.3 to -0.2) percentage vs. 0.0 (+ 0.1 to +0.5) percentage in the intervention and control groups, respectively, P less than 0.001.

Secondary

MeasureTime frame
Expected outcome 2. It is expected to evaluate the treatment satisfaction with the use of the application and the educational measures received after the intervention, as well as the participants' experience on the usability of the proposed technology. Through a questionnaire, we want to describe the patient's experience when using technology in their treatment routine ;Outcomes found 2. Regarding treatment satisfaction with the use of the application and educational measures received after the intervention, we observed that 86% of the participants used the internet routinely and 98% liked to use the technology, 62% found it easy to use. use, 72 percent felt that the app helped in managing the disease, and 50 percent had some difficulty managing the technology.

Countries

Brazil

Contacts

Public ContactLuciana Bahia

Universidade do Estado do Rio de Janeiro

lucianabahia@gmail.com+55(21)988747204

Outcome results

None listed

Source: REBEC (via WHO ICTRP)